Non-endocrine applications of somatostatin and octreotide acetate: facts and flights of fancy
Section snippets
Everett J. Mozell received his M.D. from Upstate Medical Center in Syracuse, New York in 1983. He completed his general surgical training at the Oregon Health Sciences University in Portland, Oregon before undertaking a thoracic surgery fellowship in England. He currently is a clinical research assistant at Oregon Health Sciences University and is in private surgical practice at the Salem Clinic in Salem, Oregon. His research interests include endocrine and non-endocrine tumors of the pancreas.
References (263)
- et al.
Inhibition of gastrin and gastric acid secretion
Lancet
(1974) - et al.
Inhibition of cholecystokinin-pancreozymin release by somatostatin
Lancet
(1977) - et al.
Somatostatin and the gastrointestinal tract
Clin Gastroenterol
(1980) - et al.
Somatostatin and analogs lack splanchnic vasoconstrictive effects in anesthetized pigs
J Surg Res
(1987) - et al.
Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects
Gastroenterology
(1981) - et al.
Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin
Gastroenterology
(1981) - et al.
Effect of exogenous somatostatin infusion on gastrointestinal blodd flow and hormones in the conscious dog
Gastroenterology
(1985) - et al.
Somatostatin: peripheral vasoconstrictive activity and interaction with monoamines in man
Regul Pept
(1987) - et al.
Mechanisms for direct inhibition of canine gastric parietal cells by somatostatin
J Biol Chem
(1987) - et al.
Gastric secretion and gastrin under progressive doses of somatostatin-14 and somatostatin-28 administered intraperitoneally to the rat
Regul Pept
(1988)
Direct inhibition of gastric acid and pepsin secretion by growth hormone release-inhibiting hormone in cats
Lancet
The effect of somatostatin on baseline and stimulated acid secretion and vascular histamine release from the totally isolated vascularly perfused rat stomach
Regul Pept
Effects of glucagon, secretin and vasoactive intestinal polypeptide on gastric somatostatin and gastrin release from isolated perfused rat stomach
Gastroenterology
Differential regulation of gastrin and somatostatin secretion from isolated perfused rat stomachs
Gastroenterology
Effects of carbachol on gastrin and somatostatin release in rat antral tissue culture
Gastroenterology
Somatostatin inhibition of basal and carbachol-stimulated gastrin release in rat antral organ culture
Gastroenterology
Somatostatin modulation of neurally mediated pepsinogen secretion from frog esophageal mucosa
Biochim Biophys Acta
Somatostatin in the treatment of haematemesis and melaena
Lancet
Somatostatin and cimetidine in peptic ulcer haemorrhage: a randomised controlled trial
Lancet
Somatostatin for cimetidine-resistant gastroduodenal hemorrhage
Lancet
Effect of acid and pepsin on blood coagulation and platelet aggregation: a possible contributor to prolonged gastroduodenal mucosal hemorrhage
Gastroenterology
Role of epidermal growth factor in healing of chronic gastroduodenal ulcers in rats
Gastroenterology
Effects of somatostatin on the exocrine pancreas and the release of duodenal hormones
Metabolism
Treatment of pancreatic cutaneous fistula with a somatostatin analogue
Am J Surg
Treatment of nonendocrine gastrointestinal disorders with octreotide acetate
Metabolism
Effect of octreotide acetate on pancreatic exocrine function
Am J Surg
Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro
Endocrinology
Hypothalamic peptide that inhibits immunoreactive pituitary growth hormone
Science
Effects of somatostatin on the secretion of thyrotropin and prolactin
Endocrinology
Inhibition of the in vitro secretion of insulin by an extract of pancreatic α1 cells
Endocrinology
The effect of somatostatin on release and insulinotropic action of gastric inhibitory polypeptide
Can J Physiol Pharmacol
Somatostatin: some aspects of its physiology
Inhibitory effect of somatostatin on human pancreatic polypeptide secretion
Life Sci
Proceedings: Effect of somatostatin on motilin and gastric emptying
Gut
Somatostatin suppresses secretin and pancreatic exocrine secretion
Science
Effects of somatostatin and gastroenteropancreatic hormones in a malignant insulinoma patient
Clin Res
Adult onset nesidioblastosis: response of glucose, insulin and secondary peptides to therapy with sandostatin
Am J Gastroenterol
Effect of somatostatin analog on peptide release and tumor growth in the Zollinger-Ellison syndrome
Surg Gynecol Obstet
Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995
N Engl J Med
Treatment of carcinoid syndrome and VIPoma with a long-acting somatostatin analogue (SMS 201-995)
Scand J Gastroenterol
Long-term management of acromegaly with sandostatin
Horm Res
The sensitivity of growth hormone and prolactin secretion to the somatostatin analog SMS 201-995 in patients with prolactinomas and acromegaly
Clin Endocrinol
Treatment of inappropriate secretion of thyrotropin with somatostatin analog SMS 201-995
Horm Res
Effect of a long-acting somatostatin derivative SMS 201-995 (Sandostatin) on glucose homeostasis in type I diabetes mellitus
Horm Res
Prevention of human diabetic ketoacidosis by somatostatin: evidence for an essential role of glucagon
N Engl J Med
Effects of somatostatin on gallbladder emptying in man
Clin Res
Somatostatin: occurrence in urinary bladder epithelium and renal tubules of the toad, buto marinus
Science
Immunohistochemical demonstration of somatostatin-containing cells in the human, dog and rat thyroids
Tohoku J Exp Med
Distribution of somatostatin in the rat brain: telencephalon and diencephalon
Brain Res
Effects of a somatostatin analogue SMS 201-995 in hepatic hemodynamics in the pig and on intravariceal pressure in man
Br J Surg
Cited by (0)
Everett J. Mozell received his M.D. from Upstate Medical Center in Syracuse, New York in 1983. He completed his general surgical training at the Oregon Health Sciences University in Portland, Oregon before undertaking a thoracic surgery fellowship in England. He currently is a clinical research assistant at Oregon Health Sciences University and is in private surgical practice at the Salem Clinic in Salem, Oregon. His research interests include endocrine and non-endocrine tumors of the pancreas.
Eugene A. Woltering is Associate Professor of Surgery in the Division of Surgical Oncology of Oregon Health Sciences University in Portland, Oregon. After completing a general surgical residency at Vanderbilt University he trained in surgical oncology at the National Cancer Institute and Ohio State University. His major clinical interests are endocrine surgery and breast disease. His research interests include the study of mechanisms of peptide hormone action and tumor angiogenesis.
Thomas M. O'Dorisio is professor of Physiology and Endocrinology at Ohio State University, Director of the Division of Endocrinology at Ohio State University, Director of the Division of Endocrinology and Metabolism, and Associate Program Director at Ohio State University Clinical Research Center. He has been affiliated with Ohio State University for the past 17 years. His major research interests are gastrointestinal hormones, endocrine tumors of the gastrointestinal tract, and diabetes mellitus.